Related Experiment Video
Updated: Jun 3, 2026

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
Pathophysiology of translational regulation by microRNAs in multiple sclerosis
1Department of Neuropathology, University Medical Center, Georg August University, Göttingen, Germany. andreas.junker@med.uni-goettingen.de
Abstract:
MicroRNAs (miRNAs) comprise a group of several hundred, small non-coding RNA molecules with a fundamental influence on the regulation of gene expression. Certain miRNAs are altered in blood cells of multiple sclerosis (MS), and active and inactive MS brain lesions have distinct miRNA expression profiles. Several miRNAs such as miR-155 or miR-326 are considerably overexpressed in active MS lesions versus controls, and mice lacking these miRNAs either through knock-out (miR-155) or by in vivo silencing (miR-326) show a reduction of symptoms in experimental autoimmune encephalomyelitis (EAE), a model system for multiple sclerosis. This review describes miRNAs regulated in the blood or in brain lesions of MS patients in the context of their previously described functions in physiology and pathophysiology.
Insights
MicroRNAs (miRNAs) are small RNA molecules impacting gene expression. Altered miRNAs in multiple sclerosis (MS) blood and brain lesions suggest they are key players in MS pathophysiology.
Area of Science:
- Molecular Biology
- Neuroscience
- Genetics
Background:
- MicroRNAs (miRNAs) are small, non-coding RNA molecules regulating gene expression.
- Specific miRNAs are dysregulated in multiple sclerosis (MS) patients' blood and brain lesions.
- Distinct miRNA expression profiles exist between active and inactive MS brain lesions.
Purpose of the Study:
- To review miRNAs implicated in multiple sclerosis (MS).
- To discuss the roles of these miRNAs in MS pathophysiology and normal physiology.
Main Methods:
- Literature review of studies on miRNA expression in MS patients.
- Analysis of miRNA functions in physiological and pathological contexts.
- Examination of experimental autoimmune encephalomyelitis (EAE) models for MS.
Main Results:
- Certain miRNAs, like miR-155 and miR-326, are overexpressed in active MS lesions.
- Genetic or functional silencing of miR-155 and miR-326 reduces symptoms in EAE models.
- miRNA dysregulation is observed in both MS blood and brain tissues.
Conclusions:
- MicroRNAs play a significant role in the pathogenesis of multiple sclerosis (MS).
- Targeting specific miRNAs may offer therapeutic strategies for MS.
- Further research into miRNA functions is crucial for understanding MS.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Regulation of Expression at Multiple Steps
Translational Regulation
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...

